Salvatore La Rosa, PhD, is the Chief Scientific Officer at the Kidney Cancer Association (KCA), bringing over 20 years of experience in advancing research programs and treatment pipelines for rare diseases. Previously, he served as CSO at the Children's Tumor Foundation, where he led innovative initiatives in grant-making, team science, and data sharing, contributing to the development of new therapies for neurofibromatosis and schwannomatosis. With a strong background in drug discovery, biotechnology, and non-profit management, Dr. La Rosa is dedicated to advancing kidney cancer research, fostering collaboration among medical, research, and patient communities, and accelerating the development of new therapies. He holds a PhD in Medicinal Chemistry from the University of Strathclyde and an MS in Organic Chemistry from the University of Messina.